{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:48:51Z","timestamp":1772750931919,"version":"3.50.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s17413","type":"journal-article","created":{"date-parts":[[2012,3,26]],"date-time":"2012-03-26T04:13:04Z","timestamp":1332735184000},"page":"149","source":"Crossref","is-referenced-by-count":5,"title":["Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections"],"prefix":"10.2147","author":[{"given":"Stanley","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,3]]},"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=12386","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:11:50Z","timestamp":1477865510000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/critical-appraisal-of-ceftaroline-in-the-management-of-community-acqui-peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s17413","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}